Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT03025958
Ages eligible for Study
65 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Previously untreated and histologically confirmed locoregionally advanced nasopharyngeal carcinoma
A history of another invasive cancer, prior RT to the head and neck area, prior cytotoxic chemotherapy or anti-EGFR therapy or the presence of any serious medical conditions, supposed to live less than 6 months.
All locations for NCT03025958
Hangzhou, Zhejiang, China, 310022
Put me in touch!
View full eligibility
Tris trial is registered with FDA with number: NCT03025958. The sponsor of the trial is Zhejiang Cancer Hospital and it is looking for 30 volunteers for the current phase.
Official trial title:
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!